We are delighted to announce the second round of successful applications for the Institute for Translational Medicine and Therapeutics’ (ITMAT) Transdisciplinary Award Program (TAPITMAT), supported by the School of Medicine and CHOP. The quality of all applications was extremely high and the funding decisions, made by members of the Internal Advisory Board, were extremely difficult.
The selected projects range across the breadth of biology, integrate diverse disciplines and investigators from many schools of Penn, The Children’s Hospital of Philadelphia, and the Wistar Institute reflecting their interaction in the context of the Clinical and Translational Science Award. They are uniformly of high scientific quality, interdisciplinary and translational in nature.
ITMAT is delighted with the number and quality of applications responsive to this call for awards and will continue to develop the program further in future years.
Jean Bennett, M.D., Ph.D., and Joshua Lipschutz, M.D.
Gene therapy for autosomal dominant polycystic kidney disease
Douglas Cines, M.D. and Andrew Tsourkas, Ph.D.
Platelet-mediated thrombolysis
George Coukos, M.D., Ph.D. and Bruce L. Levin, Ph.D.
Development of ovarian cancer immunotherapy using rapidly activate peritoneal monocytes
Michael A. Elovitz, M.D. and Akiva S. Cohen, Ph.D.
Perturbations in neural development and function contribute to adverse neurologic outcomes in preterm neonates.
Liselotte E. Jensen, Ph.D., and Meenhard Herlyn, D.V.M., D.Sc.
Novel immune response modifying therapy for psoriasis
Barry L. Ziober, Ph.D., Haim H. Bau, Ph.D., and So-Jung Park, Ph.D.
Microfluidics for gene expression pattern recognition
